RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shravan Kumar Komaragiri to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Shravan Kumar Komaragiri has written about Xenograft Model Antitumor Assays.
Shravan Kumar Komaragiri
Connection Strength
0.034
Xenograft Model Antitumor Assays
  1. Joshi JB, Patel D, Morton DJ, Sharma P, Zou J, Hewa Bostanthirige D, Gorantla Y, Nagappan P, Komaragiri SK, Sivils JC, Xie H, Palaniappan R, Wang G, Cox MB, Chaudhary J. Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52. Mol Oncol. 2017 04; 11(4):337-357.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support